Sign up USA
Proactive Investors - Run By Investors For Investors

M Pharmaceutical Inc to seek partners to distribute diabetic pain products

The firm purchased topical products for the relief of diabetic neuropathy symptoms via its earlier acquisition of Cincinatti-based 40Js.
M Pharmaceutical Inc to seek partners to distribute diabetic pain products
The pain is caused by elevated blood sugar levels

M Pharmaceutical Inc (CNSX:MQ) revealed it will immediately seek partners to market and distribute products for the relief of pain suffered by diabetics.

The firm purchased  topical products for the relief of diabetic neuropathy symptoms via its earlier acquisition of Cincinatti-based 40Js.

Gary Thompson, president and chief executive officer, said: " Diabetic neuropathy, or diabetic nerve pain, is a result of permanent damage to the nerves of the hand and feet caused by elevated blood sugar levels.

"This pain is different from pain you may have experienced from arthritis, a headache or even a sports injury."

He added it can affect the most simple of day-to-day activities for over 400 million people worldwide.

"Our product's innovative topical formulations of menthol and L-arginine paired with other key ingredients has been shown to ease this hand and leg pain. Our goal is to have distribution contracts in place and product shipping by mid summer."

The clinical-stage firm is developing innovative technologies for obesity and weight management.

View full MQ profile View Profile

M Pharmaceutical Timeline

Related Articles

blood_56ceb82789b61.jpg
December 15 2016
The company's nominated adviser said a partnership deal should be signed by the end of 2016
cancer cells
July 12 2017
The US-based, London-listed healthcare group topped expectations with its latest results and analysts are tipping it for more success this year
cancer cells
February 10 2017
It has already got £7.2mln of the £14.9mln it is looking to raise, which will help fund the development of two promising cancer drug candidates: RXC004 and RXC005
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use